Biotechs flip to gene silencing for weight problems medication that may last more than Wegovy
Enticed through the immense marketplace opened through GLP-1 weight reduction medication Wegovy and Zepbound, a handful of biotech firms are looking to increase next-generation, longer-lasting treatments in keeping with an overly other